C&SR Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $82.8K

  • Investors
  • 2

C&SR General Information

Description

Developer of humanized animal models and preclinical R&D services intended to improve the safety and efficacy evaluation of anticancer drugs and cell therapies. The company's platform features high-percentage human immune cell engraftment and immune reconstitution protocols, enabling clients to generate reliable clinical efficacy data through personalized humanized rodent models for oncology and immunology.

Contact Information

Website
www.cnsr.co.kr
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Room 412, Building C
  • Indeokwon IT Valley, 40 Imi-ro
  • Uiwang-si, Gyeonggi-do 16006
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Laboratory Services (Healthcare)
Biotechnology
Corporate Office
  • Room 412, Building C
  • Indeokwon IT Valley, 40 Imi-ro
  • Uiwang-si, Gyeonggi-do 16006
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

C&SR Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Equity Crowdfunding 28-Apr-2025 $82.8K Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
To view C&SR’s complete valuation and funding history, request access »

C&SR Patents

C&SR Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025263722-A1 Personalized humanized animal model transplanted with peripheral blood mononuclear cells (pbmcs) and production method therefor Pending 21-Jun-2024
WO-2025089495-A1 Production of ultra-advanced humanized mouse model based on umbilical cord blood-derived hematopoietic stem cell transplantation and immune cell expansion technology, and method for producing same Inactive 26-Oct-2023

C&SR Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
ActnerLab Accelerator/Incubator Minority
Tech Incubator Program for Startup Accelerator/Incubator
To view C&SR’s complete investors history, request access »

C&SR FAQs

  • When was C&SR founded?

    C&SR was founded in 2022.

  • Where is C&SR headquartered?

    C&SR is headquartered in Uiwang-si, South Korea.

  • What industry is C&SR in?

    C&SR’s primary industry is Drug Discovery.

  • Is C&SR a private or public company?

    C&SR is a Private company.

  • What is C&SR’s current revenue?

    The current revenue for C&SR is .

  • How much funding has C&SR raised over time?

    C&SR has raised $82.8K.

  • Who are C&SR’s investors?

    ActnerLab and Tech Incubator Program for Startup have invested in C&SR.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process